Trending Stock News

Point72 Asset Management LP Maintains Stake in Vulcan Matls Co (VMC); Hartwell J M Limited Partnership Has Trimmed Portola Pharmaceuticals (PTLA) Position as Market Valuation Declined

Vulcan Materials Company (NYSE:VMC) Logo

Hartwell J M Limited Partnership decreased its stake in Portola Pharmaceuticals (PTLA) by 17.84% based on its latest 2017Q4 regulatory filing with the SEC. Hartwell J M Limited Partnership sold 6,325 shares as the company’s stock declined 43.57% with the market. The hedge fund held 29,125 shares of the health care company at the end of 2017Q4, valued at $1.42M, down from 35,450 at the end of the previous reported quarter. Hartwell J M Limited Partnership who had been investing in Portola Pharmaceuticals for a number of months, seems to be less bullish one the $2.72 billion market cap company. The stock increased 0.95% or $0.39 during the last trading session, reaching $41.36. About 851,714 shares traded. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has declined 20.86% since May 21, 2017 and is downtrending. It has underperformed by 32.41% the S&P500.

Steve Cohen increased its stake in Vulcan Matls Co (VMC) by 60.83% based on its latest 2017Q4 regulatory filing with the SEC. Point72 Asset Management Lp bought 631,880 shares as the company’s stock declined 7.65% with the market. The hedge fund run by Steve Cohen held 1.67M shares of the mining & quarrying of nonmetallic minerals (no fuels) company at the end of 2017Q4, valued at $214.46 million, up from 1.04 million at the end of the previous reported quarter. Point72 Asset Management Lp who had been investing in Vulcan Matls Co for a number of months, seems to be bullish on the $17.08B market cap company. The stock increased 2.51% or $3.16 during the last trading session, reaching $129.2. About 1.66M shares traded or 16.53% up from the average. Vulcan Materials Company (NYSE:VMC) has risen 1.98% since May 21, 2017 and is uptrending. It has underperformed by 9.57% the S&P500.

More notable recent Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) news were published by: Fool.com which released: “3 Small-Cap Biotech Stocks With Big Catalysts in May” on April 30, 2018, also 247Wallst.com with their article: “Portola Pharmaceuticals Wins Big With FDA Approval” published on May 04, 2018, Seekingalpha.com published: “Portola Pharmaceuticals’ (PTLA) CEO William Lis on Q1 2018 Results – Earnings Call Transcript” on May 15, 2018. More interesting news about Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) were released by: Fool.com and their article: “Portola Takes Another Big Step Forward” published on May 14, 2018 as well as Seekingalpha.com‘s news article titled: “Buy Diamondback Energy On Declines – Cramer’s Lightning Round (5/11/18)” with publication date: May 14, 2018.

Investors sentiment decreased to 1.36 in Q4 2017. Its down 0.80, from 2.16 in 2017Q3. It fall, as 32 investors sold PTLA shares while 45 reduced holdings. 30 funds opened positions while 75 raised stakes. 56.35 million shares or 0.04% more from 56.33 million shares in 2017Q3 were reported. Gam Hldg Ag invested in 0.23% or 151,600 shares. Royal Financial Bank Of Canada reported 98,786 shares. D E Shaw Inc holds 0.07% or 1.03M shares in its portfolio. Polar Ltd Liability Partnership has 0.3% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Qs Invsts Llc reported 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Dekabank Deutsche Girozentrale has invested 0.01% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Wells Fargo Communications Mn holds 0.01% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 686,816 shares. 30,313 were reported by Parametric Ltd Liability. Cadian Cap Management Lp owns 4.52% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 1.52M shares. National Bank & Trust Of America Corp De has invested 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Ghost Tree Llc has 225,000 shares for 2.57% of their portfolio. Loring Wolcott And Coolidge Fiduciary Advsr Llp Ma holds 0% or 10 shares in its portfolio. Atlantic Tru Gp Ltd Liability Co stated it has 0% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Blume Capital Mgmt Inc holds 0.03% or 1,000 shares in its portfolio. Comml Bank Of Montreal Can reported 0% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA).

Hartwell J M Limited Partnership, which manages about $535.54 million and $532.32 million US Long portfolio, upped its stake in Alibaba Group (NYSE:BABA) by 27,680 shares to 131,925 shares, valued at $22.75M in 2017Q4, according to the filing. It also increased its holding in Vantiv Inc. (NYSE:VNTV) by 38,450 shares in the quarter, for a total of 47,250 shares, and has risen its stake in Procter & Gamble Co (NYSE:PG).

Analysts await Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) to report earnings on August, 8. They expect $-1.50 earnings per share, down 22.95% or $0.28 from last year’s $-1.22 per share. After $-1.28 actual earnings per share reported by Portola Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 17.19% negative EPS growth.

Since December 15, 2017, it had 0 buys, and 2 insider sales for $607,613 activity. Another trade for 1,135 shares valued at $43,663 was sold by Fu Tao.

Among 7 analysts covering Portola Pharmaceuticals (NASDAQ:PTLA), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Portola Pharmaceuticals has $81 highest and $24 lowest target. $65.50’s average target is 58.37% above currents $41.36 stock price. Portola Pharmaceuticals had 42 analyst reports since August 5, 2015 according to SRatingsIntel. As per Friday, August 19, the company rating was maintained by Morgan Stanley. As per Tuesday, December 19, the company rating was maintained by Oppenheimer. The firm has “Buy” rating by Credit Suisse given on Wednesday, September 20. The firm earned “Buy” rating on Friday, May 27 by Citigroup. Citigroup maintained the stock with “Buy” rating in Wednesday, August 10 report. The firm earned “Buy” rating on Monday, June 26 by Morgan Stanley. Cowen & Co maintained the shares of PTLA in report on Friday, May 4 with “Buy” rating. The firm has “Buy” rating given on Wednesday, August 5 by Cowen & Co. Citigroup upgraded the stock to “Buy” rating in Tuesday, January 3 report. The firm has “Outperform” rating by Credit Suisse given on Thursday, August 24.

Investors sentiment increased to 1.25 in Q4 2017. Its up 0.19, from 1.06 in 2017Q3. It increased, as 35 investors sold VMC shares while 152 reduced holdings. 65 funds opened positions while 168 raised stakes. 118.61 million shares or 2.84% more from 115.33 million shares in 2017Q3 were reported. Parametric Portfolio Associates Ltd Com has 0.05% invested in Vulcan Materials Company (NYSE:VMC). Ci Investments reported 465,031 shares or 0.57% of all its holdings. Hanson And Doremus Mgmt holds 0.01% of its portfolio in Vulcan Materials Company (NYSE:VMC) for 300 shares. L And S Advisors invested in 0.07% or 3,605 shares. The New York-based Adirondack Tru has invested 0% in Vulcan Materials Company (NYSE:VMC). Brown Advisory reported 0% of its portfolio in Vulcan Materials Company (NYSE:VMC). Impax Asset Mngmt Ltd owns 95,000 shares for 0.7% of their portfolio. 2,794 were accumulated by Paloma Mgmt Company. 8,710 were accumulated by Shell Asset Management. Zweig holds 120,355 shares or 1.68% of its portfolio. Drw Securities Ltd Liability holds 0.02% in Vulcan Materials Company (NYSE:VMC) or 1,848 shares. Franklin Resource has invested 0.01% of its portfolio in Vulcan Materials Company (NYSE:VMC). Louisiana State Employees Retirement reported 8,000 shares or 0.05% of all its holdings. Advisor Ltd Liability Corporation owns 1,950 shares for 0.05% of their portfolio. Apg Asset Mgmt Nv holds 0.04% in Vulcan Materials Company (NYSE:VMC) or 207,123 shares.

Among 14 analysts covering Vulcan Materials Company (NYSE:VMC), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Vulcan Materials Company has $158.0 highest and $96 lowest target. $132.93’s average target is 2.89% above currents $129.2 stock price. Vulcan Materials Company had 43 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Monday, July 24 with “Buy”. On Wednesday, August 5 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm earned “Buy” rating on Wednesday, June 8 by Goldman Sachs. The stock of Vulcan Materials Company (NYSE:VMC) earned “Buy” rating by Stifel Nicolaus on Monday, May 16. As per Monday, June 19, the company rating was maintained by RBC Capital Markets. The rating was maintained by Bank of America with “Neutral” on Monday, February 5. The stock of Vulcan Materials Company (NYSE:VMC) has “Hold” rating given on Friday, February 16 by Jefferies. The stock of Vulcan Materials Company (NYSE:VMC) earned “Buy” rating by BB&T Capital on Wednesday, May 4. The stock of Vulcan Materials Company (NYSE:VMC) has “Buy” rating given on Wednesday, May 2 by Bank of America. Citigroup maintained the shares of VMC in report on Thursday, January 25 with “Buy” rating.

Vulcan Materials Company (NYSE:VMC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *